Pharmacotherapy of neuropsychiatric symptoms: opportunities, challenges and current prospects

Peter V Rabins and Constantine G Lyketsos

doi:10.1038/ncpneuro0492 | Full Text | PDF (58K)

Why hasn't neuroprotection worked in Parkinson's disease?

Karl Kieburtz and Bernard Ravina

doi:10.1038/ncpneuro0491 | Full Text | PDF (84K)

Hippocampal dysfunction associated with depression in temporal lobe epilepsy

doi:10.1038/ncpneuro0444 | Full Text | PDF (65K)

Antimyelin antibodies are not prognostic for progression to multiple sclerosis

doi:10.1038/ncpneuro0454 | Full Text | PDF (65K)

'Benign' multiple sclerosis: difficult to characterize and predict clinical course

doi:10.1038/ncpneuro0455 | Full Text | PDF (81K)

The insula is the critical neural substrate in cigarette addiction

doi:10.1038/ncpneuro0456 | Full Text | PDF (86K)

Memantine and gabapentin are useful in the treatment of congenital nystagmus

doi:10.1038/ncpneuro0457 | Full Text | PDF (102K)

Neural stem cell grafts differentiate in adult rat spinal cord

doi:10.1038/ncpneuro0458 | Full Text | PDF (102K)

Prion disease: recovery of cognitive deficits following early intervention

doi:10.1038/ncpneuro0459 | Full Text | PDF (119K)

Targeted reinnervation enhances control of prosthetic limb

doi:10.1038/ncpneuro0460 | Full Text | PDF (102K)

Transient orexin receptor blockade induces sleep without cataplexy

doi:10.1038/ncpneuro0461 | Full Text | PDF (119K)

The PPN is a target for deep brain stimulation in Parkinson's disease

doi:10.1038/ncpneuro0462 | Full Text | PDF (83K)

More-efficient brain circuitry associated with risk of schizophrenia?

doi:10.1038/ncpneuro0463 | Full Text | PDF (67K)

Early benefits of neutralizing antibodies against IFN- in multiple sclerosis

doi:10.1038/ncpneuro0468 | Full Text | PDF (83K)

Incidence of anticoagulant-associated intracerebral hemorrhage rising in the US

doi:10.1038/ncpcardio0842 | Full Text | PDF (65K)

Music-based training program improves motor skills following stroke

doi:10.1038/ncpneuro0469 | Full Text | PDF (65K)

Antipsychotics in patients with Alzheimer's disease—what is their clinical value?

Clive Ballard, Jane Fossey and Samantha Sharp

doi:10.1038/ncpneuro0472 | Full Text | PDF (90K)

Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia

Caroline H Williams-Gray and Roger A Barker

doi:10.1038/ncpneuro0471 | Full Text | PDF (88K)

Antithrombotic treatment and stroke severity in patients with atrial fibrillation

Natan M Bornstein and Eitan Auriel

doi:10.1038/ncpneuro0450 | Full Text | PDF (87K)

Diagnostic testing in episodic migraine: should it include magnetic resonance venography?

Stephen D Silberstein

doi:10.1038/ncpneuro0453 | Full Text | PDF (85K)

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

R Loch Macdonald, Ryszard M Pluta and John H Zhang

doi:10.1038/ncpneuro0490 | Full Text | PDF (316K)

Therapy Insight: inborn errors of metabolism in adult neurology—a clinical approach focused on treatable diseases

Frédéric Sedel, Olivier Lyon-Caen and Jean-Marie Saudubray

doi:10.1038/ncpneuro0494 | Full Text | PDF (288K)